Presentation Safety and Efficacy for the Use of Prasugrel in Patients Undergoing Percutaneous Coronary Intervention and Anticoagulated with Bivalirudin. Presenter: Ana Laynez January 03, 2012 REGISTER for free or LOG IN to view this content CAD Pharma Presentation TCT 2012 Up Next Presentation Paraoxonase-1 (PON1) Activity And PON1 Polymorphisms Have No Effect On Platelet Reactivity In Patients Treated With Clopidogrel Presenter: Jean-Pierre P. Dery January 03, 2012 More slides + Presentation Favorable Long-Term Clinical Outcomes Of Intravascular Ultrasound-Guided Provisional Single Stent Strategy for Feasible Unprotected Left Main Trunk Distal Bifurcation Lesions Presenter: Takayoshi Toba January 03, 2012 Presentation The Role of Pull-Back Pressure Gradient in Percutaneous Transluminal Angioplasty for Central Vein stenosis in Dialysis Patients Presenter: Yu Sheng Lin January 03, 2012 We Recommend
Presentation Paraoxonase-1 (PON1) Activity And PON1 Polymorphisms Have No Effect On Platelet Reactivity In Patients Treated With Clopidogrel Presenter: Jean-Pierre P. Dery January 03, 2012
Presentation Favorable Long-Term Clinical Outcomes Of Intravascular Ultrasound-Guided Provisional Single Stent Strategy for Feasible Unprotected Left Main Trunk Distal Bifurcation Lesions Presenter: Takayoshi Toba January 03, 2012
Presentation The Role of Pull-Back Pressure Gradient in Percutaneous Transluminal Angioplasty for Central Vein stenosis in Dialysis Patients Presenter: Yu Sheng Lin January 03, 2012